The powerful placebo effect: fact or fiction?

Journal of Clinical Epidemiology
G S Kienle, H Kiene

Abstract

In 1955, Henry K. Beecher published the classic work entitled "The Powerful Placebo." Since that time, 40 years ago, the placebo effect has been considered a scientific fact. Beecher was the first scientist to quantify the placebo effect. He claimed that in 15 trials with different diseases, 35% of 1082 patients were satisfactorily relieved by a placebo alone. This publication is still the most frequently cited placebo reference. Recently Beecher's article was reanalyzed with surprising results: In contrast to his claim, no evidence was found of any placebo effect in any of the studies cited by him. There were many other factors that could account for the reported improvements in patients in these trials, but most likely there was no placebo effect whatsoever. False impressions of placebo effects can be produced in various ways. Spontaneous improvement, fluctuation of symptoms, regression to the mean, additional treatment, conditional switching of placebo treatment, scaling bias, irrelevant response variables, answers of politeness, experimental subordination, conditioned answers, neurotic or psychotic misjudgment, psychosomatic phenomena, misquotation, etc. These factors are still prevalent in modern placebo literature. The pl...Continue Reading

References

Dec 1, 1977·Biofeedback and Self-regulation·C J Peek
Sep 1, 1992·Pain·Coralyn W Whitney, Michael Von Korff
Feb 1, 1986·British Journal of Rheumatology·I HashishM Harris
Jan 1, 1989·Stereotactic and Functional Neurosurgery·D M LongR B Kouba
Jan 1, 1988·Journal of Psychosomatic Research·K H HoW Harvey
Sep 26, 1968·The New England Journal of Medicine·M M Reidenberg, D T Lowenthal
Oct 1, 1983·Statistics in Medicine·C J McDonaldG P McCabe
Jan 1, 1984·Pain·W E FordyceD L Rock
Aug 26, 1995·BMJ : British Medical Journal·E Ernst, K L Resch
Oct 1, 1994·Lancet·P C Gøtzsche
Jan 1, 1996·European Journal of Clinical Pharmacology·A Hróbjartsson
May 22, 1954·Journal of the American Medical Association·S WOLF, R H PINSKY
Jun 1, 1954·The American Journal of Medicine·L LASAGNAH K BEECHER
Dec 26, 1955·Minerva medica·L SCHIAVETTI, F FERRARIS
Feb 9, 1957·Journal of the American Medical Association·R E WELLS
Nov 1, 1959·The Journal of Pharmacy and Pharmacology·D I COOMBER, B A ROSE
Feb 1, 1964·Annals of Internal Medicine·D M GREEN
Sep 1, 1950·The Journal of Pharmacology and Experimental Therapeutics·A S KEATS, H K BEECHER
Dec 29, 1951·Journal of the American Medical Association·A S KEATSH K BEECHER
Jun 21, 1952·Lancet·B R HILLIS
May 6, 1950·Journal of the American Medical Association·W S COEJ M KINSMAN
Apr 8, 1949·Science·L N Gay, P E Carliner
Dec 22, 1956·Journal of the American Medical Association·M DYKEN, P T WHITE

❮ Previous
Next ❯

Citations

Apr 26, 2008·Der Anaesthesist·J Oeltjenbruns, M Schäfer
Apr 14, 2005·World Journal of Surgery·Sarah J L EdwardTeresa Swift
Oct 26, 2007·European Journal of Applied Physiology·Luana CollocaCarlo Adolfo Porro
Dec 24, 2005·Journal of Behavioral Medicine·Andrew L GeersKristin Kosbab
Nov 4, 2010·Journal of Behavioral Medicine·Andrew L GeersSuzanne G Helfer
Dec 19, 2008·Journal of General Internal Medicine·Nirav R ShahWalter F Stewart
Feb 13, 2009·Current Allergy and Asthma Reports·James N Baraniuk
Jun 9, 2005·Journal of Clinical Epidemiology·Paul Knipschild, Arnoud Arntz
Dec 20, 2000·Journal of Psychosomatic Research·J S Odendaal
Aug 31, 1999·Survey of Ophthalmology·C E Margo
Feb 10, 2000·Survey of Ophthalmology·B Sardi
Jul 12, 2002·The Urologic Clinics of North America·Mark A Moyad
Oct 18, 2002·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·C A SpeedB L Hazleman
May 15, 2002·Journal of Clinical Epidemiology·Asbjørn Hróbjartsson
Sep 16, 2005·Journal of Personality and Social Psychology·Andrew L GeersSuzanne G Helfer
Feb 26, 2004·Psychological Bulletin·Steve Stewart-Williams, John Podd
May 24, 2001·The New England Journal of Medicine·A Hróbjartsson, P C Gøtzsche
Jan 1, 2008·Journal of Clinical and Experimental Neuropsychology·Barry S OkenDawn Peters
Dec 17, 2009·The American Journal of Bioethics : AJOB·Robin Nunn
Dec 17, 2009·The American Journal of Bioethics : AJOB·Bennett Foddy
Jan 6, 2005·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Harald Walach, Wayne B Jonas
Jun 24, 2008·Brain : a Journal of Neurology·Barry S Oken
Jan 2, 2003·Journal of the National Cancer Institute·Gisèle Chvetzoff, Ian F Tannock
Oct 23, 2004·Holistic Nursing Practice·Gloria F Donnelly
Dec 23, 1999·Current Opinion in Pulmonary Medicine·I Ziment
Sep 23, 2008·Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine·John BroolingPeter Fricker
Apr 3, 2008·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Marjean Taylor KulpUNKNOWN Convergence Insufficiency Treatment Trial (CITT) Investigator Group
May 18, 2011·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Klaus LindeKarin Meissner
May 18, 2011·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Harald Walach
May 18, 2011·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Karin MeissnerLuana Colloca
Feb 12, 2011·Journal of Paediatrics and Child Health·Vanessa Clifford
May 30, 2009·Journal of Biomedicine & Biotechnology·A SaponeM Paolini
Feb 11, 2009·Public Health Genomics·S B HagaJ O'Daniel
Jun 10, 2005·Current Controlled Trials in Cardiovascular Medicine·Holger DiedrichsRobert H G Schwinger
May 9, 2008·BMC Complementary and Alternative Medicine·Tyler C SmithMargaret A K Ryan
Aug 12, 2009·BMC Health Services Research·Margrit FässlerNikola Biller-Andorno
Dec 6, 2006·Medicine and Science in Sports and Exercise·Christopher J BeedieAbigail J Foad
Oct 27, 2009·Perspectives in Biology and Medicine·Franklin G MillerTed J Kaptchuk
Jul 13, 2011·Annals of Family Medicine·Bruce BarrettShari Barlow

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Asbjørn Hróbjartsson, Peter C Gøtzsche
European Journal of Clinical Pharmacology
Asbjørn Hróbjartsson
Lancet
D M Chaput de Saintonge, A Herxheimer
BMJ : British Medical Journal
E Ernst, K L Resch
© 2021 Meta ULC. All rights reserved